Notch1 expression on T cells is not required for CD4+ T helper differentiation

European Journal of Immunology

Volumn 34, Issue 6, 2004, Pages 1588-1596

  Tacchini Cottier, Fabienne ^a,b   Allenbach, Cindy ^a,b   Otten, Luc A ^b   Radtke, Freddy ^b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Cytokines; Leishmania major; Notch1; Th1; Th2 cells

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4; MESSENGER RNA; NOTCH1 RECEPTOR; CELL SURFACE RECEPTOR; NOTCH1 PROTEIN, MOUSE; PROTOZOON ANTIBODY; RNA; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELL MATURATION; CELL POLARITY; CELL SPECIFICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENE ACTIVATION; GENE INACTIVATION; GENETIC TRANSCRIPTION; HELPER CELL; IN VITRO STUDY; IN VIVO STUDY; LEISHMANIA MAJOR; LEISHMANIASIS; LYMPH NODE CELL; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PARASITE IMMUNITY; PARASITE VIRULENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL; TH2 CELL; ANIMAL; BIOSYNTHESIS; BLOOD; C57BL MOUSE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; GENETICS; GERMFREE ANIMAL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE MUTANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTIBODIES, PROTOZOAN; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; FEMALE; INTERFERON TYPE II; INTERLEUKIN-4; LEISHMANIA MAJOR; LEISHMANIASIS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, NOTCH1; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SPECIFIC PATHOGEN-FREE ORGANISMS; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; TH2 CELLS; TRANSCRIPTION FACTORS;

EID: 3242712463     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200324337     Document Type: Article

References (50)

1. Artavanis-Tsakonas, S., Matsuno, K. and Fortini, M. E., Notch signaling. Science 1995. 268: 225-232.
2. Artavanis-Tsakonas, S., Rand, M. D. and Lake, R. J., Notch signaling: cell fate control and signal integration in development. Science 1999. 284: 770-776.
3. Shutter, J. R., Scully, S., Fan, W., Richards, W. G., Kitajewski, J., Deblandre, G. A., Kintner, C. R. and Stark, K. L., DII4, a novel Notch ligand expressed in arterial endothelium. Genes Dev. 2000. 14: 1313-1318.
4. Rebay, I., Fleming, R. J., Fehon, R. G., Cherbas, L., Cherbas, P. and Artavanis-Tsakonas, S., Specific EGF repeats of Notch mediate interactions with Delta and Serrate: implications for Notch as a multifunctional receptor. Cell 1991. 67: 687-699.
5. Deftos, M. L. and Bevan, M. J., Notch signaling in T cell development. Curr. Opin. Immunol. 2000. 12: 166-172.
6. Allman, D., Punt, J. A., Izon, D. J., Aster, J. C. and Pear, W. S., An invitation to T and more: notch signaling in lymphopoiesis. Cell 2002. 109: S1-11.
7. Radtke, F., Wilson, A., Ernst, B. and MacDonald, H. R., The role of Notch signaling during hematopoietic lineage commitment. Immunol. Rev. 2002. 187: 65-74.
8. Hasserjian, R. P., Aster, J. C., Davi, F., Weinberg, D. S. and Sklar, J., Modulated expression of notch1 during thymocyte development. Blood 1996. 88: 970-976.
9. Felli, M. P., Maroder, M., Mitsiadis, T. A., Campese, A. F., Bellavia, D., Vacca, A., Mann, R. S., Frati, L., Lendahl, U., Gulino, A. and Screpanti, I., Expression pattern of notch1, 2 and 3 and Jagged1 and 2 in lymphoid and stromal thymus components: distinct ligand-receptor interactions in intrathymic T cell development. Int. Immunol. 1999. 11: 1017-1025.
10. Radtke, F., Wilson, A., Stark, G., Bauer, M., van Meerwijk, J., MacDonald, H. R. and Aguet, M., Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 1999. 10: 547-558.
11. Wilson, A., MacDonald, H. R. and Radtke, F., Notch 1-deficient common lymphold precursors adopt a B cell fate in the thymus. J. Exp. Med. 2001. 194: 1003-1012.
12. Izon, D. J., Aster, J. C., He, Y., Wang, A., Karnell, F. G., Patriub, V., Xu, L., Bakkour, S., Rodriguez, C., Allman, D. and Pear, W. S., Deltex1 redirects lymphoid progenitors to the B cell lineage by antagonizing notch1. Immunity 2002. 16: 231-243.
13. Koch, U., Lacombe, T. A., Holland, D., Bowman, J. L., Cohen, B. L., Egan, S. E. and Guidos, C. J., Subversion of the T/B lineage decision in the thymus by lunatic fringe-mediated inhibition of Notch-1. Immunity 2001. 15: 225-236.
14. Pui, J. C., Allman, D., Xu, L., DeRocco, S., Karnell, F. G., Bakkour, S., Lee, J. Y., Kadesch, T., Hardy, R. R., Aster, J. C. and Pear, W. S., Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity 1999. 11: 299-308.
15. Washburn, T., Schweighoffer, E., Gridley, T., Chang, D., Fowlkes, B. J., Cado, D. and Robey, E., Notch activity influences the alphabeta versus gammadelta T cell lineage decision. Cell 1997. 88: 833-843.
16. Robey, E., Chang, D., Itano, A., Cado, D., Alexander, H., Lans, D., Weinmaster, G. and Salmon, P., An activated form of Notch influences the choice between CD4 and CD8 T cell lineages. Cell 1996. 87: 483-492.
17. Yasutomo, K., Doyle, C., Miele, L. and Germain, R. N., The duration of antigen receptor signaling determines CD4+ versus CD8+ T cell lineage fate. Nature 2000. 404: 506-510.
18. Hoyne, G. F., Le Roux, I., Corsin-Jimenez, M., Tan, K., Dunne, J., Forsyth, L. M., Dallman, M. J., Owen, M. J., Ish-Horowicz, D. and Lamb, J. R., Serrate1-induced notch signaling regulates the decision between immunity and tolerance made by peripheral CD4+ T cells. Int. Immunol. 2000. 12: 177-185.
19. Abbas, A., Murphy, K. M. and Sher, A., Functional diversity of helper T lymphocytes. Nature 1996. 383: 787-793.
20. Murphy, K. M. and Reiner, S. L., The lineage decisions of helper T cells. Nat Rev. Immunol. 2002. 2: 933-944.
21. O'Garra, A., Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 1998. 8: 275-283.
22. Constant, S. L. and Bottomly, K., Induction of Th1 and Th2 CD4+ T cell responses: The alternative approaches. Annu. Rev. Immunol. 1997. 15: 297-322.
23. Campbell, K. A., Ovendale, P. J., Kennedy, M. K., Fanslow, W. C., Reed, S. G. and Maliszewski, C. R., CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 1996. 4: 283-289.
24. Soong, L., Xu, J.-C., Grewa, L. I. S., Kima, P., Sun, J., Longley, B. J., Ruddle, N. H., McMahon-Pratt, D. and Flavell, R. A., Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 1996. 4: 263-273.
25. Kamanaka, M., Yu, P., Yasui, T., Yoshida, K., Kawabe, T., Horii, T., Kishimoto, T. and Kikutani, H., Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 1996. 4: 275-281.
26. Coyle, A. J. and Gutierrez-Ramos, J. C., The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function. Nat. Immunol. 2001. 2: 203-209.
27. Fowell, D. J., Magram, J., Turck, C. W., Killeen, N. and Locksley, R. M., Impaired Th2 subset development in the absence of CD4. Immunity 1997. 6: 559-569.
28. Brown, D. R., Moskowitz, N. H., Killeen, N. and Reiner, S. L., A role for CD4 in peripheral T cell differentiation. J. Exp. Med. 1997. 186: 101-107.
29. Maekawa, Y., Tsukumo, S., Chiba, S., Hirai, H., Hayashi, Y., Okada, H., Kishihara, K. and Yasutomo, K., Delta1-Notch3 interactions bias the functional differentiation of activated CD4+ T cells. Immunity 2003. 19: 549-559.
30. Wong, K. K., Carpenter, M. J., Young, L. L., Walker, S. J., McKenzie, G., Rust, A. J., Ward, G., Packwood, L., Wahl, K., Delriviere, L., Hoyne, G., Gibbs, P., Champion, B. R., Lamb, J. R. and Dallman, M. J., Notch ligation by Delta1 inhibits peripheral immune responses to transplantation antigens by a CD8+ cell-dependent mechanism. J. Clin. Invest. 2003. 112: 1741-1750.
31. Reiner, S. L. and Locksley, R. M., The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 1995. 13: 151-177.
32. Sadick, M. D., Heinzel, F. P., Holaday, B. J., Pu, R. T., Dawkins, R. S. and Locksley, R. M., Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon-γ independent mechanism. J. Exp. Med. 1990. 171: 115-127.
33. Himmelrich, H., Parra-Lopez, C., Tacchini-Cottier, F., Louis, J. A. and Launois, P., The IL-4 rapidly produced in BALB/c mice after infection with Leishmania major downregulates the IL-12 receptor b2 chain expression on CD4+ T cells resulting in a state of unresponsiveness to IL-12. J. Immunol. 1998. 161: 6156-6163.
34. Wolfer, A., Wilson, A., Nemir, M., MacDonald, H. R. and Radtke, F., Inactivation of Notch1 impairs VDJbeta rearrangement and allows pre-TCR-independent survival of early alpha beta lineage thymocytes. Immunity 2002. 16: 869-879.
35. Wolfer, A., Bakker, T., Wilson, A., Nicolas, M., Ioannidis, V., Littman, D. R., Lee, P. P., Wilson, C. B., Held, W., MacDonald, H. R. and Radtke, F., Inactivation of Notch 1 in immature thymocytes does not perturb CD4 or CD8 T cell development. Nat. Immunol. 2001. 2: 235-241.
36. Glimcher, L. H. and Murphy, K. M., Lineage commitment in the immune system: the T helper lymphocyte grows up. Genes Dev. 2000. 14: 1693-1711.
37. Grogan, J. L., Mohrs, M., Harmon, B., Lacy, D. A., Sedat, J. W. and Locksley, R. M., Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity 2001. 14: 205-215.
38. Snapper, C. M. and Paul, W. E., Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 1987. 236: 944-947.
39. Faquim-Mauro, E. L., Coffman, R. L., Abrahamsohn, I. A. and Macedo, M. S., Cutting edge: mouse IgG1 antibodies comprise two functionally distinct types that are differentially regulated by IL-4 and IL-12. J. Immunol. 1999. 163: 3572-3576.
40. Bogdan, C., Rollinghoff, M. and Diefenbach, A., Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr. Opin. Immunol. 2000. 12: 64-76.
41. Beebe, A. M., Cua, D. J. and Coffman, R. L., Genetic control of T helper subset differentiation in Leishmania major infection of mice. Microbes Infect. 1999. 1: 89-94.
42. Han, H., Tanigaki, K., Yamamoto, N., Kuroda, K., Yoshimoto, M., Nakahata, T., Ikuta, K. and Honjo, T., Inducible gene knockout of transcription factor recombination signal binding protein-J reveals its essential role in T versus B lineage decision. Int. Immunol. 2002. 14: 637-645.
43. Louis, J. A., Pedrazzini, T., Titus, R. G., Muller, I., Farrell, J. P., Kindler, V., Vassalli, P., Marchal, G. and Milon, G., Subsets of specific T cells and experimental cutaneous leishmaniasis. Ann. Pasteur Immunol. 1987. 138: 755-758.
44. Titus, R. G., Marchand, M., Boon, T. and Louis, J. A., A limiting dilution assay for quantifying Leishmania major in tissue of infected mice. Parasite Immunol. 1985. 7: 545-555.
45. Taswell, C., Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J. Immunol. 1981. 126: 1614-1619.
46. Reiner, S. L., Zheng, S., Corry, D. B. and Locksley, R. M., Constructing polycompetitor cDNAs for quantitative PCR. J. Immunol. Methods 1993. 165: 37-46.
47. Otten, L. A., Tacchini-Cottier, F., Lohoff, M., Annunziato, F., Cosmi, L., Scarpellino, L., Louis, J., Steimle, V., Reith, W. and Acha-Orbea, H., Deregulated MHC class II transactivator expression leads to a strong Th2 bias in CD4+ T lymphocytes. J. Immunol. 2003. 170: 1150-1157.
48. Slade, S. J. and Langhorne, J., Production of interferon-γ during infection of mice with Plasmodium chabaudi chabaudi. Immunobiology 1989. 179: 353-365.
49. Favre, N. and Erb, P., Use of the CTL44 cell line, a derivate of CTL/L cells, to identify and quantify mouse interleukin-4 by bioassay. J. Immunol. Methods 1993. 164: 213-220.
50. Chakour, R., Guler, R., Bugnon, M., Allenbach, C., Garcia, I., Mauel, J., Louis, J. and Tacchini-Cottier, F., Both the Fas ligand and inducible nitric oxide synthase are needed for control of parasite replication within lesions in mice infected with Leishmania major whereas the contribution of tumor necrosis factor is minimal. Infect. Immun. 2003. 71: 5287-5295.